Page last updated: 2024-10-30

metformin and Diplopia

metformin has been researched along with Diplopia in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Diplopia: A visual symptom in which a single object is perceived by the visual cortex as two objects rather than one. Disorders associated with this condition include REFRACTIVE ERRORS; STRABISMUS; OCULOMOTOR NERVE DISEASES; TROCHLEAR NERVE DISEASES; ABDUCENS NERVE DISEASES; and diseases of the BRAIN STEM and OCCIPITAL LOBE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colapinto, P1
Aslam, SA1
Frangouli, O1
Joshi, N1
Lee, S1
Tsirbas, A1
Goldberg, RA1
McCann, JD1

Other Studies

2 other studies available for metformin and Diplopia

ArticleYear
Undiagnosed type 2 diabetes mellitus presenting with orbital cellulitis.
    Orbit (Amsterdam, Netherlands), 2008, Volume: 27, Issue:5

    Topics: Anti-Bacterial Agents; Combined Modality Therapy; Decompression, Surgical; Diabetes Mellitus, Type 2

2008
Thiazolidinedione induced thyroid associated orbitopathy.
    BMC ophthalmology, 2007, Apr-26, Volume: 7

    Topics: Diplopia; Disease Progression; Drug Therapy, Combination; Exophthalmos; Female; Graves Ophthalmopath

2007